More
    Guided Solutions - Connecting Talent With Innovation/div>

    Cardionomic completes enrolment for cardiac neurostimulation device trials

    US-based Cardionomic has completed the patient enrolment in its two pilot studies, STIM-ADHF and STOP-ADHF, evaluating the cardiac pulmonary nerve stimulation (CPNS) system in...

    GYDER® Surgical announces successful first surgical cases in India

    MULGRAVE, Australia and PALO ALTO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- GYDER ® Surgical, a MedTech company specialising in intuitive, non-invasive orthopaedic navigation...

    Vivasure treats first patient with large-hole closure system in clinical study

    Vivasure Medical has treated the first patient in a clinical study investigating its large-hole synthetic closure system in patients undergoing percutaneous cardiovascular procedures. The successful...

    Carmat implants Aeson artificial heart in patient

    Advanced total artificial heart designer and developer Carmat has announced the first Aeson heart implantation in a patient suffering from a cardiac tumour. The patient...

    RevBio to commence human trial for regenerative bone adhesive

    RevBio has secured approval from the US Food and Drug Administration to start a first-in-human clinical trial for its regenerative bone adhesive for cranial...

    GIE Medical enrolls first subject in trial of drug-coated balloon

    US-based clinical-stage company GIE Medical in the US has enrolled the first patient in the trial of a drug-coated balloon (DCB) for the treatment...

    Patient enrolment concludes in Neuspera System trial

    Neuspera Medical has concluded enrolment of patients and implant procedures for the SANS-UUI pivotal clinical study of its minimally invasive implant, Neuspera System. The implant...

    Alafair Biosciences’s VersaWrap device receives FDA 510(k) clearance

    Image credit: Alafair Biosciences/PRNewswire.Alafair Biosciences has received 510(k) clearance from the US Food and Drug Administration (FDA) for its VersaWrap class II medical device. The approval enables...

    BiVACOR wins IDE to start first-in-human study for artificial heart

    The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH), greenlighting the way for...

    Latest articles